DENG Zhang-li, WU Dao-shen, LI Yan-liang, TAN Wei-guo. Discussion of the clinical features of 110 cases with drug-resistant tuberculosis[J]. Journal of Tuberculosis and Lung Health
, 2015, 4(2): 113-115. doi: 10.3969/j.issn.2095-3755.2015.02.009
[1] World Health Organization.Multidrug and extensively drug-resistant TB(M/XDR-TB):2010 global report on surveillance and response. Generva: World Health Organization,2010:18. [2] 世界卫生组织.耐药结核病管理指南(2011年更新版).李亮,许绍发,主译.北京: WHO结核病研究和培训合作中心,中国疾控中心结核病防治临床中心,中华医学会结核病学分会,2011. [3] 中国防痨协会基础专业委员会.结核病诊断细菌学检验规程.北京:中国教育文化出版社,2006:49-64. [4] Gandhi NR, Moll A, Sturm AW, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa.Lancet,2006,368(9547):1575-1580. [5] 孟凡亮,刘庆福,李建之,等.泰安市结核病防治院2011年痰培养阳性肺结核就诊患者的耐药状况分析. 中国防痨杂志,2012,34(11):736-739. [6] 谭卫国,杨应周,程锦泉,等.抗结核固定复合制剂与板式组合药治疗肺结核可行性的对照研究.中国防痨杂志,2005,27(4):209-214. [7] 苏伟,阮云洲,赵津,等.91例耐多药肺结核患者抗结核药物不良反应发生情况分析.中国防痨杂志,2014,36(7):570-575.